… Address correspondence to Laura C. Coates, MBChB, MRCP, PhD, Leeds Institute of
Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK. E-mail: LC…

Objective: To develop an evidence-based guideline for the pharmacologic and nonpharmacologic
treatment of psoriatic arthritis (PsA), as a collaboration between the American College …

Objective: To create minimal disease activity (MDA) criteria for psoriatic arthritis (PsA). With
recent therapeutic advances, this is now a goal for treatment and may represent a measure to …

Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in
2012, but the evidence for these recommendations was only of indirect nature. These …

Since the second version of the Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …

Background Early intervention and tight control of inflammation optimise outcomes in rheumatoid
arthritis but these approaches have not yet been studied in psoriatic arthritis. We aimed …

Background Wide-ranging prevalence estimates of psoriatic arthritis (PsA) in patients with
psoriasis have been reported. Objectives To assess the prevalence and incidence of PsA in …

Objective To evaluate the efficacy of infliximab in HLA–B27–positive patients with magnetic
resonance imaging (MRI)–determined early sacroiliitis, using both clinical and MRI …

Psoriatic arthritis (PsA) accounts for around 20% of referrals to the early arthritis clinic and
presents a significant diagnostic and management challenge. Early diagnosis is important to …

Objective. New criteria for minimal disease activity (MDA) in psoriatic arthritis (PsA) have been
developed. The aim is to provide further validation of these criteria using data obtained in …